Becton Dickinson Profit Margin 2006-2018 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of September 30, 2018 is 1.47%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $62.744B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $25.428B 9.71
AmerisourceBergen (ABC) United States $19.755B 14.09
Align Technology (ALGN) United States $17.542B 44.76
Cardinal Health (CAH) United States $16.902B 11.35
Laboratory Of America Holdings (LH) United States $16.592B 15.02
Henry Schein (HSIC) United States $12.945B 21.28
Cooper (COO) United States $12.531B 22.57
DENTSPLY SIRONA (XRAY) United States $8.170B 16.32
West Pharmaceutical Services (WST) United States $7.920B 39.31
Merit Medical Systems (MMSI) United States $3.175B 37.60
Patterson (PDCO) United States $2.334B 16.41
CONMED (CNMD) United States $1.914B 31.79
STAAR Surgical (STAA) United States $1.889B 194.59
Atrion (ATRI) United States $1.348B 38.53
Antares Pharma (ATRS) United States $0.523B 0.00
Invacare (IVC) United States $0.220B 0.00
Lifevantage (LFVN) United States $0.173B 24.54
Endologix (ELGX) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.057B 25.60
Aceto (ACET) United States $0.053B 0.00
Biolase (BIOL) United States $0.029B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00